Wendy McDermott - Jan 3, 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Human Resources
Signature
/s/ Wendy E. McDermott
Stock symbol
LXRX
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 08:34 PM
Next filing
Feb 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +85.2K $0.00 85.2K Jan 3, 2022 Common Stock 85.2K $3.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (1/3/2023) and vests 1/48th per month for each month of service thereafter.